Skip to contentM
Microbot Medical Inc.
M
MBOTMicrobot Medical Inc. Q2 2018 · 10-Q
Revenue—
Net Income-$1.89M-$1.89MN/M vs Q2 2017 EPS Diluted-$0.66-$0.66N/M vs Q2 2017 Operating Income-$1,892,000N/M Operating Cash Flow-$1,349,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Microbot Medical Inc. · CIK 883975 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,440,000N/M ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end